These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 24131485)

  • 61. Is it time to adopt external beam radiotherapy in the NCCN guidelines as a therapeutic strategy for intermediate/advanced hepatocellular carcinoma?
    Jiang W; Zeng ZC
    Oncology; 2013; 84 Suppl 1():69-74. PubMed ID: 23428862
    [TBL] [Abstract][Full Text] [Related]  

  • 62. [Influence of treatment of hepatocellular carcinoma before liver transplantation on post transplant tumor recurrence and survival].
    Díaz-Sánchez A; Matilla A; Núñez O; Merino B; Peligros I; Rincón D; Salcedo M; Lo Iacono O; Vega Catalina M; Clemente G; Bañares R
    Gastroenterol Hepatol; 2010 Mar; 33(3):155-64. PubMed ID: 19945770
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Stereotactic body radiation therapy combined with transcatheter arterial chemoembolization for small hepatocellular carcinoma.
    Honda Y; Kimura T; Aikata H; Kobayashi T; Fukuhara T; Masaki K; Nakahara T; Naeshiro N; Ono A; Miyaki D; Nagaoki Y; Kawaoka T; Takaki S; Hiramatsu A; Ishikawa M; Kakizawa H; Kenjo M; Takahashi S; Awai K; Nagata Y; Chayama K
    J Gastroenterol Hepatol; 2013 Mar; 28(3):530-6. PubMed ID: 23216217
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Clinical Outcomes and Prognostic Factors of High-Dose Proton Beam Therapy for Peripheral Stage I Non-Small-Cell Lung Cancer.
    Hatayama Y; Nakamura T; Suzuki M; Azami Y; Ono T; Yabuuchi T; Hayashi Y; Kimura K; Hirose K; Wada H; Hareyama M; Kikuchi Y; Takai Y
    Clin Lung Cancer; 2016 Sep; 17(5):427-432. PubMed ID: 26725851
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Combination treatment of localized concurrent chemoradiation therapy and transarterial chemoembolization in locally advanced hepatocellular carcinoma with intrahepatic metastasis.
    Park MS; Kim SU; Park JY; Kim DY; Ahn SH; Han KH; Chon CY; Seong J
    Cancer Chemother Pharmacol; 2013 Jan; 71(1):165-73. PubMed ID: 23079897
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Successful two-stage operation for esophageal necrosis due to proton beam therapy followed by sorafenib in a case of large hepatocellular carcinoma.
    Higaki E; Fukaya M; Miyata K; Kawai R; Abe T
    Surg Case Rep; 2020 Jun; 6(1):138. PubMed ID: 32548687
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Phase II Study of Personalized Peptide Vaccination with Both a Hepatitis C Virus-Derived Peptide and Peptides from Tumor-Associated Antigens for the Treatment of HCV-Positive Advanced Hepatocellular Carcinoma Patients.
    Yutani S; Ueshima K; Abe K; Ishiguro A; Eguchi J; Matsueda S; Komatsu N; Shichijo S; Yamada A; Itoh K; Sasada T; Kudo M; Noguchi M
    J Immunol Res; 2015; 2015():473909. PubMed ID: 26539554
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Study of local three-dimensional conformal radiotherapy combined with transcatheter arterial chemoembolization for patients with stage III hepatocellular carcinoma.
    Li B; Yu J; Wang L; Li C; Zhou T; Zhai L; Xing L
    Am J Clin Oncol; 2003 Aug; 26(4):e92-9. PubMed ID: 12902905
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Recurrences of hepatocellular carcinoma following initial remission by transcatheter arterial chemoembolization.
    Lee JK; Chung YH; Song BC; Shin JW; Choi WB; Yang SH; Yoon HK; Sung KB; Lee YS; Suh DJ
    J Gastroenterol Hepatol; 2002 Jan; 17(1):52-8. PubMed ID: 11895553
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Multi-Institutional Phase II Study of High-Dose Hypofractionated Proton Beam Therapy in Patients With Localized, Unresectable Hepatocellular Carcinoma and Intrahepatic Cholangiocarcinoma.
    Hong TS; Wo JY; Yeap BY; Ben-Josef E; McDonnell EI; Blaszkowsky LS; Kwak EL; Allen JN; Clark JW; Goyal L; Murphy JE; Javle MM; Wolfgang JA; Drapek LC; Arellano RS; Mamon HJ; Mullen JT; Yoon SS; Tanabe KK; Ferrone CR; Ryan DP; DeLaney TF; Crane CH; Zhu AX
    J Clin Oncol; 2016 Feb; 34(5):460-8. PubMed ID: 26668346
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Hepatocellular carcinoma downstaging in liver transplantation.
    Yu CY; Ou HY; Huang TL; Chen TY; Tsang LL; Chen CL; Cheng YF
    Transplant Proc; 2012 Mar; 44(2):412-4. PubMed ID: 22410030
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Intraperitoneal perfusion of cytokine-induced killer cells with local hyperthermia for advanced hepatocellular carcinoma.
    Wang XP; Xu M; Gao HF; Zhao JF; Xu KC
    World J Gastroenterol; 2013 May; 19(19):2956-62. PubMed ID: 23704829
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Proton beam therapy for hepatocellular carcinoma patients with severe cirrhosis.
    Hata M; Tokuuye K; Sugahara S; Fukumitsu N; Hashimoto T; Ohnishi K; Nemoto K; Ohara K; Matsuzaki Y; Akine Y
    Strahlenther Onkol; 2006 Dec; 182(12):713-20. PubMed ID: 17149578
    [TBL] [Abstract][Full Text] [Related]  

  • 74. The safety and efficacy of high-dose proton beam radiotherapy for hepatocellular carcinoma: a phase 2 prospective trial.
    Bush DA; Kayali Z; Grove R; Slater JD
    Cancer; 2011 Jul; 117(13):3053-9. PubMed ID: 21264826
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Clinical factors related to recurrence after hepatic arterial concurrent chemoradiotherapy for advanced but liver-confined hepatocellular carcinoma.
    Cha H; Yoon HI; Lee IJ; Koom WS; Han KH; Seong J
    J Radiat Res; 2013 Nov; 54(6):1069-77. PubMed ID: 23633620
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Proton beam therapy for recurrent ovarian carcinoma: A case report.
    Kino T; Ando N; Ogawara Y; Shigeta H
    J Obstet Gynaecol Res; 2019 Sep; 45(9):1952-1956. PubMed ID: 31332888
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Chest wall toxicity after hypofractionated proton beam therapy for liver malignancies.
    Yeung R; Bowen SR; Chapman TR; MacLennan GT; Apisarnthanarax S
    Pract Radiat Oncol; 2018; 8(4):287-293. PubMed ID: 29452863
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Radioembolisation with yttrium‒90 microspheres versus sorafenib for treatment of advanced hepatocellular carcinoma (SARAH): study protocol for a randomised controlled trial.
    Vilgrain V; Abdel-Rehim M; Sibert A; Ronot M; Lebtahi R; Castéra L; Chatellier G;
    Trials; 2014 Dec; 15():474. PubMed ID: 25472660
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Proton Beam Radiotherapy and Concurrent Chemotherapy for Unresectable Stage III Non-Small Cell Lung Cancer: Final Results of a Phase 2 Study.
    Chang JY; Verma V; Li M; Zhang W; Komaki R; Lu C; Allen PK; Liao Z; Welsh J; Lin SH; Gomez D; Jeter M; O'Reilly M; Zhu RX; Zhang X; Li H; Mohan R; Heymach JV; Vaporciyan AA; Hahn S; Cox JD
    JAMA Oncol; 2017 Aug; 3(8):e172032. PubMed ID: 28727865
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Proton beam therapy for aged patients with hepatocellular carcinoma.
    Hata M; Tokuuye K; Sugahara S; Tohno E; Nakayama H; Fukumitsu N; Mizumoto M; Abei M; Shoda J; Minami M; Akine Y
    Int J Radiat Oncol Biol Phys; 2007 Nov; 69(3):805-12. PubMed ID: 17524568
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.